- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02136277
Vascular Changes During Colorectal Surgery (MaMiFlo)
Measurement of Changes in Macro- and Microvascular Blood Flow During Major Colorectal Surgery
The purpose of this study is to investigate whether increases in the blood flow from the heart (the cardiac output), induced by the administration of intravenous fluids, lead to an increase in the blood flow to the vital organs, in patients undergoing bowel surgery.
This study will involve 2 phases. Firstly, potential volunteers will be invited to meet the research fellow (medical doctor) undertaking this study, who will check their suitability to participate in the study and who will obtain informed consent.
The second phase is the study itself which will take place whilst volunteers are having their bowel operation. They will attend theatre in the normal way, but once they have been anaesthetised (put to sleep), a special monitor called an oesophageal doppler probe will be placed into their oesophagus (food pipe) via the nose. This monitor is frequently used in bowel surgery to help assess how much intravenous fluid to administer to a patient by measuring the cardiac output (the amount of blood pumped out of the heart each minute). Using the cannula (drip) already inserted in the arm to allow administration of the anaesthetic, a special fluid, called an ultrasound contrast agent, will be injected into the drip, to allow a contrast enhanced ultrasound scan of the abdominal organs to be performed, to measure the blood flow to these organs. A small sample of blood will be taken from the earlobe to allow us to measure a chemical in the blood called lactate.
After this, intravenous fluid will be administered in order to increase the amount of blood pumped out of the heart. Once the oesophageal doppler monitor suggests that an adequate amount of fluid has been given, a second ultrasound scan will be performed to measure whether blood flow to the abdominal organs has also increased. A further blood sample will be taken from your earlobe to measure any change in lactate level.
At the completion of the operation, a third ultrasound scan will be performed and another sample of blood taken from the earlobe, to help assess blood flow to the organs.
Study Overview
Status
Intervention / Treatment
Detailed Description
Potential participants (patients with colorectal cancer offered an operation) will be highlighted from the Derbyshire NHS trusts colorectal multidisciplinary team meeting. All patients who fulfil entry requirements will be seen by the research fellow after their outpatient meeting with their particular surgeon (if they agree). Information packs containing details of the study (information sheet and consent form) will be given and any questions answered. Patients will be allowed to take the packs away with them and decide whether they would be keen to participate. Interested patients will be consented by the research fellow during their subsequent pre-operative clinic appointment.
The study will take place intra-operatively. Monitoring will be instituted as determined necessary by the attending anaesthetists, but as a minimum will consist of pulse oximetry, ECG and non-invasive blood pressure recording. Intravenous cannulae will be sited and general anaesthesia induced by the anaesthetist responsible for the patient, as would be normal for this type of surgery. Once the patient has been transferred to the operating theatre, the research fellow will insert an ODM probe via either the nasal or oral route and the CO and SV will be measured; this constitutes normal care. A sterile Phillips iU22 USS probe will be placed on the patient's abdomen and the research fellow will administer SonoVue contrast agent intravenously via the cannula already sited to facilitate anaesthesia, up to a maximum dose of 2.4ml. Visceral MVBF will be measured using this CEUS technique. Capillary blood samples will be taken from earlobe for measurement of blood lactate levels by the research fellow. At this stage, as would typically occur during an operation of this nature, the research fellow will administer intravenous colloid suspension in boluses of 3ml/kg, up to a maximum of 15ml/kg, until the CO has been maximised, as judged by the ODM. At this stage, the research fellow will perform a further CEUS of the abdominal viscera by administering Sonovue contrast agent (2nd dose of up to 2.4ml) and measuring MVBF with the Phillips iU22. Repeat samples of capillary blood will be drawn to measure the lactate level by the research fellow. At the end of the operation, a 3rd CEUS of the abdominal viscera, along with further SV & CO readings, will be made.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: John P Williams, PhD
- Phone Number: 01332 724641
- Email: john.williams7@nhs.net
Study Locations
-
-
Derbyshire
-
Derby, Derbyshire, United Kingdom, DE22 3NE
- Recruiting
- Royal Derby Hospital
-
Principal Investigator:
- John P Williams, PhD
-
Sub-Investigator:
- David Read, BMBS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged 18 - 80 years
- Confirmed colorectal cancer
- Offered surgery by Derbyshire colorectal multidisciplinary team
- No metastatic disease
- Able to consent in English by themselves
Exclusion Criteria:
- Metastatic disease
- Oesophageal varices
- Patients with recent acute coronary syndrome (symptoms involving the heart) or unstable ischaemic cardiac disease (reduced blood supply to the heart);
- Patients known to have right-to-left shunts (abnormal movement of blood within the heart), severe pulmonary hypertension (high blood pressure in the pulmonary artery, the blood vessel that leads from the heart to the lungs), uncontrolled hypertension (high blood pressure) or adult respiratory distress syndrome (severe fluid build-up in both lungs);
- Pregnant or breast-feeding women;
- Known sensitivity to Sonovue;
- Prolonged QT syndrome
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Colorectal patients
Subjects undergoing colorectal surgery
|
Administered in 250ml boluses, until cardiac output has been optimised.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in microvascular blood flow during colorectal surgery
Time Frame: Immediately following optimisation of cardiac output
|
Immediately following optimisation of cardiac output
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: John P Williams, PhD, University of Nottingham
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13115
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Undergoing Open Resection of Colorectal Tumours
-
Shaare Zedek Medical CenterUnknownPatients Undergoing Open Heart Surgery | Patients Undergoing Lung SurgeryIsrael
-
University of SaskatchewanUnknownPatients Undergoing Open Hernia Repair | Patients Undergoing Ventral or Inguinal Hernia RepairCanada
-
Yonsei UniversityNot yet recruitingPatients Undergoing Transurethral Resection of BladderKorea, Republic of
-
Johann Wolfgang Goethe University HospitalCompletedPatients Undergoing Any Kind of SurgeryGermany
-
The First Affiliated Hospital of Anhui Medical...CompletedLong-term Heart-specific Mortality in the Presence of Competing Risks Among Patients With Gastric Adenocarcinoma Undergoing Resection and Chemotherapy
-
Inje UniversityCompletedEnd Tidal Carbon Dioxide of Patients Undergoing General AnesthesiaKorea, Republic of
-
Exero Medical Ltd.CompletedOpen/ Laparoscopic/ Robotic Resection of the ColonIsrael
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
-
Cantonal Hospital of St. GallenCompletedGiven Indication for Open Resection of Colorectal Cancer
-
Cairo UniversityNorhan Abdelaleem Ali; Ahmed Shaker Ragab; Yasmina sayed Abdrabo IsmaelCompletedComparing of 2 Different Volumes in ESPB in Patients Undergoing MRMEgypt
Clinical Trials on Hartmann's solution
-
Seoul National University HospitalGC PharmaCompletedLiving Donor Liver TransplantationKorea, Republic of
-
Clinical Research Centre, MalaysiaCompleted
-
Nepean Blue Mountains Local Health DistrictInnogene Kalbiotech Pte. LtdCompleted
-
Manchester University NHS Foundation TrustUniversity of ManchesterRecruitingSepsis | Septic Shock | Shock, ToxicUnited Kingdom
-
State University of New York at BuffaloTerminatedDiabetic KetoacidosisUnited States
-
St George's, University of LondonCompleted
-
Makerere UniversityCompletedNormal Anion Gap Metabolic AcidosisUganda
-
Austin HealthUnknownShock | Critical IllnessAustralia
-
SangartCompletedHypoxia | HypotensionSweden
-
SangartCompletedProstate Cancer | Surgery | Blood Loss, SurgicalUnited States